» Articles » PMID: 29606816

Antibiotic Susceptibility and Treatment Response in Bacterial Skin Infection

Overview
Journal Ann Dermatol
Specialty Dermatology
Date 2018 Apr 3
PMID 29606816
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Bacterial skin infections occur secondarily in conditions involving a vulnerable skin barrier such as atopic eczema, as well as primarily such as impetigo. They are mainly caused by and . Recently, the prevalence of methicillin-resistant has been increasing.

Objective: To determine the characteristics of community-acquired bacterial skin infections, to observe their antibiotic susceptibility patterns, and to evaluate factors contributing to the treatment response.

Methods: We retrospectively reviewed outpatients under 30 years old from 2010 to 2015, from whom we had taken skin swabs for antibiotic susceptibility testing. We collected clinical and microbiological characteristics from the medical records.

Results: We evaluated the culture results of 197 patients and reviewed their medical records. Overall, 86.3% (n=170) of the patients responded to the initial treatment regimen. was the most commonly isolated pathogen (52.6%) and showed a high resistance rate to penicillin (90.9%) and oxacillin (36.3%). In the multivariable logistic regression analysis, resistance to 3 or more antibiotics (=0.044), culture amounts described as "many" (=0.040), and non-systemic antibiotic use (<0.001) were significantly associated with lower treatment response. However, methicillin resistance was not associated with lower treatment response both in univariable and multivariable analyses.

Conclusion: Among young patients, was the most predominant pathogen present in bacterial skin infections. Resistance to high numbers of antibiotics and the use of non-systemic antibiotics were associated with lower treatment response. First-generation cephalosporins may be the most effective first-line empirical regimen for bacterial skin infections treated in outpatient settings, regardless of methicillin resistance.

Citing Articles

Development and maintenance of consensus recommendations on pediatric outpatient antibiotic therapy in Germany: a framework for rational use.

Soler Wenglein J, Simon A, Berner R, Brockmeyer H, Forster J, Hamelmann E Eur J Pediatr. 2025; 184(2):149.

PMID: 39843792 PMC: 11754357. DOI: 10.1007/s00431-024-05964-y.


Lentisk () Oil Nanoemulsions Loaded with Levofloxacin: Phytochemical Profiles and Antibiofilm Activity against spp.

Maurizi L, Lasalvia A, Fabiano M, DIntino E, Del Cioppo F, Fraschetti C Pharmaceutics. 2024; 16(7).

PMID: 39065624 PMC: 11280327. DOI: 10.3390/pharmaceutics16070927.


Fluorescent microscopy evaluation of diode laser effect on the penetration depth of turmeric (Curcuma longa) extract cream on skin tissues of Wistar rats.

Astuti S, Mawaddah A, Kusumawati I, Mahmud A, Nasution A, Purwanto B Lasers Med Sci. 2024; 39(1):79.

PMID: 38393433 DOI: 10.1007/s10103-024-04020-3.


Comparative Evaluation of Existing and Rationally Designed Novel Antimicrobial Peptides for Treatment of Skin and Soft Tissue Infections.

Ramata-Stunda A, Boroduskis M, Kaktina E, Patetko L, Kalnenieks U, Lasa Z Antibiotics (Basel). 2023; 12(3).

PMID: 36978418 PMC: 10044245. DOI: 10.3390/antibiotics12030551.


Human Skin Microbiome: Impact of Intrinsic and Extrinsic Factors on Skin Microbiota.

Skowron K, Bauza-Kaszewska J, Kraszewska Z, Wiktorczyk-Kapischke N, Grudlewska-Buda K, Kwiecinska-Pirog J Microorganisms. 2021; 9(3).

PMID: 33808031 PMC: 7998121. DOI: 10.3390/microorganisms9030543.


References
1.
Parish L, Jorizzo J, Breton J, Hirman J, Scangarella N, Shawar R . Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: results of a randomized controlled trial. J Am Acad Dermatol. 2006; 55(6):1003-13. DOI: 10.1016/j.jaad.2006.08.058. View

2.
Gulliford M, Moore M, Little P, Hay A, Fox R, Prevost A . Safety of reduced antibiotic prescribing for self limiting respiratory tract infections in primary care: cohort study using electronic health records. BMJ. 2016; 354:i3410. PMC: 4933936. DOI: 10.1136/bmj.i3410. View

3.
Odell C . Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) skin infections. Curr Opin Pediatr. 2010; 22(3):273-7. DOI: 10.1097/MOP.0b013e328339421b. View

4.
Jung M, Chung J, Lee H, Park J, Lee D, Yang J . Antibiotic Susceptibility of Staphylococcus aureus in Atopic Dermatitis: Current Prevalence of Methicillin-Resistant Staphylococcus aureus in Korea and Treatment Strategies. Ann Dermatol. 2015; 27(4):398-403. PMC: 4530149. DOI: 10.5021/ad.2015.27.4.398. View

5.
Ong P, Leung D . Bacterial and Viral Infections in Atopic Dermatitis: a Comprehensive Review. Clin Rev Allergy Immunol. 2016; 51(3):329-337. DOI: 10.1007/s12016-016-8548-5. View